Literature DB >> 573083

The heart and cardiac conduction system in thrombotic thrombocytopenic purpura. A clinicopathologic study of 17 autopsied patients.

R L Ridolfi, G M Hutchins, W R Bell.   

Abstract

The relation between the heart lesions of thrombotic thrombocytopenic purpura and clinical cardiac dysfunction was studied in 17 autopsied patients. Thirteen of the 17 patients had extensive small-vessel thromboses and in some instances hemorrhages and focal necroses within the heart. Congestive heart failure was present in nine of the 17 patients. Thrombotic microcirculatory cardiac lesions and anemia-related high cardiac output may have contributed to cardiac dysfunction. Serial histologic sections of the cardiac conducting system in 10 patients showed microthrombi in seven and associated hemorrhages in five. Lesions were localized to the atrioventricular node and His bundle parts of the system with sparing of the sinoatrial node and bundle branches. Two patients had electrocardiographic evidence suggesting lesions within conducting tissues. Thrombi and hemorrhages are common findings in the conducting tissues in thrombotic thrombocytopenic purpura and may account for cardiac arrest or transient rhythm disturbances.

Entities:  

Mesh:

Year:  1979        PMID: 573083     DOI: 10.7326/0003-4819-91-3-357

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  16 in total

1.  An unusual cause of chest pain.

Authors:  S A Brown; S Popat; R Carr
Journal:  Postgrad Med J       Date:  1997-12       Impact factor: 2.401

2.  Does this patient with thrombotic thrombocytopenic purpura have a cardiac involvement?

Authors:  Lara Zafrani; Lene Russell; Elie Azoulay
Journal:  Intensive Care Med       Date:  2018-06-04       Impact factor: 17.440

Review 3.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  J Evan Sadler
Journal:  Blood       Date:  2017-08-02       Impact factor: 22.113

Review 4.  Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: a systematic review with pooled data analysis.

Authors:  Nay M Tun; Gina M Villani
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

5.  Myocardial changes in acute Trypanosoma cruzi infection. Ultrastructural evidence of immune damage and the role of microangiopathy.

Authors:  Z A Andrade; S G Andrade; R Correa; M Sadigursky; V J Ferrans
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

6.  Experimental Trypanosoma cruzi cardiomyopathy in BALB/c mice. The potential role of intravascular platelet aggregation in its genesis.

Authors:  M A Rossi; S Gonçalves; R Ribeiro-dos-Santos
Journal:  Am J Pathol       Date:  1984-02       Impact factor: 4.307

Review 7.  Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency.

Authors:  Han-Mou Tsai
Journal:  Hematol Oncol Clin North Am       Date:  2007-08       Impact factor: 3.722

8.  Thrombotic thrombocytopenic purpura and systemic lupus erythematosus.

Authors:  D A Fox; J D Faix; J Coblyn; P Fraser; B Smith; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  1986-04       Impact factor: 19.103

9.  Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura.

Authors:  Elie Azoulay; Philippe R Bauer; Eric Mariotte; Lene Russell; Paul Knoebl; Ignacio Martin-Loeches; Frédéric Pène; Kathryn Puxty; Pedro Povoa; Andreas Barratt-Due; Jose Garnacho-Montero; Julia Wendon; Laveena Munshi; Dominique Benoit; Michael von Bergwelt-Baildon; Marco Maggiorini; Paul Coppo; Spero Cataland; Agnès Veyradier; Andry Van de Louw
Journal:  Intensive Care Med       Date:  2019-10-07       Impact factor: 17.440

10.  Dilated cardiomyopathy during the course of hemolytic uremic syndrome.

Authors:  Alexandra Alexopoulou; Spyros P Dourakis; Christos Zovoilis; Emmanouel Agapitos; Aris Androulakis; Anna Filiotou; Athanasios J Archimandritis
Journal:  Int J Hematol       Date:  2007-11       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.